2026 Kazuhiko Yanai: Neuroscience Researcher – H-Index, Publications & Awards

D-Index & Metrics

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Neuroscience	80	1638	1492	35	33	654	19558
Medicine	80	17278	16236	554	522	666	19612

Discipline name

D-Index

World Ranking

Current World Ranking

National Ranking

Current National Ranking

Publications

Citations

Neuroscience

1638

1492

654

19558

Medicine

17278

16236

554

522

666

19612

Neuroscience

D-Index

Citations

19558

World Ranking

1638

National Ranking

Medicine

D-Index

Citations

19612

World Ranking

17278

National Ranking

554

Overview

Kazuhiko Yanai is affiliated with Tohoku University in Japan and has contributed extensively to the fields of medicine, neuroscience, and biochemistry, genetics, and molecular biology. Their research spans several subfields including molecular biology, physiology, neurology, immunology, and radiology, nuclear medicine, and imaging.

The scientist's work addresses various main topics, such as:

Mast cells and histamine
Alzheimer's disease research and treatments
Sleep and wakefulness research
Neuroinflammation and neurodegeneration mechanisms
Circadian rhythm and melatonin
Olfactory and sensory function studies
Radiopharmaceutical chemistry and applications

Kazuhiko Yanai has published frequently in a range of scientific venues, notably including:

Proceedings for Annual Meeting of The Japanese Pharmacological Society
Journal of Nuclear Medicine
Current Topics in Behavioral Neurosciences
Neuropharmacology
Scientific Reports

Recent publications include:

¹⁸F-SMBT-1: A Selective and Reversible PET Tracer for Monoamine Oxidase-B Imaging, 2020, Journal of Nuclear Medicine
Histaminergic neurons in the tuberomammillary nucleus as a control centre for wakefulness, 2020, British Journal of Pharmacology
First-in-Humans Evaluation of ¹⁸F-SMBT-1, a Novel ¹⁸F-Labeled Monoamine Oxidase-B PET Tracer for Imaging Reactive Astrogliosis, 2022, Journal of Nuclear Medicine
Assessing Reactive Astrogliosis with ¹⁸F-SMBT-1 Across the Alzheimer Disease Spectrum, 2022, Journal of Nuclear Medicine
Imaging of Reactive Astrogliosis by Positron Emission Tomography, 2022, Frontiers in Neuroscience

Frequent collaborators include:

Takeo Yoshikawa
Nobuyuki Okamura
Ryuichi Harada
Yukitsuka Kudo
Shozo Furumoto

Best Publications

18F-THK523: a novel in vivo tau imaging ligand for Alzheimer’s disease

Michelle T Fodero-Tavoletti;Nobuyuki Okamura;Shozo Furumoto;Rachel S Mulligan

410
Citations
Psychosis pathways converge via D2high dopamine receptors.

Philip Seeman;Johannes Schwarz;Jiang Fan Chen;Henry Szechtman

398
Citations
18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease.

Ryuichi Harada;Nobuyuki Okamura;Shozo Furumoto;Katsutoshi Furukawa

396
Citations
Specific brain processing of facial expressions in people with alexithymia: an H215O‐PET study

Michiko Kano;Shin Fukudo;Jiro Gyoba;Miyuki Kamachi

357
Citations
Impaired locomotor activity and exploratory behavior in mice lacking histamine H1 receptors

Isao Inoue;Kazuhiko Yanai;Daisuke Kitamura;Ichiro Taniuchi

348
Citations
Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease.

Nobuyuki Okamura;Shozo Furumoto;Ryuichi Harada;Tetsuro Tago

344
Citations
2-(2-[2-Dimethylaminothiazol-5-yl]Ethenyl)-6- (2-[Fluoro]Ethoxy)Benzoxazole: A Novel PET Agent for In Vivo Detection of Dense Amyloid Plaques in Alzheimer's Disease Patients

Yukitsuka Kudo;Nobuyuki Okamura;Shozo Furumoto;Manabu Tashiro

321
Citations
Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.

Nobuyuki Okamura;Shozo Furumoto;Michelle T. Fodero-Tavoletti;Rachel S. Mulligan

304
Citations
Consensus group on new‐generation antihistamines (CONGA): present status and recommendations

S. T. Holgate;G. W. Canonica;F. E. R. Simons;M. Taglialatela

294
Citations
Behavioral Characterization of Mice Lacking Histamine H3 Receptors

Hiroshi Toyota;Christine Dugovic;Muriel Koehl;Aaron D. Laposky

291
Citations
Quinoline and Benzimidazole Derivatives: Candidate Probes for In Vivo Imaging of Tau Pathology in Alzheimer's Disease

Nobuyuki Okamura;Takahiro Suemoto;Shozo Furumoto;Masako Suzuki

268
Citations
Imaging of central itch modulation in the human brain using positron emission tomography.

Hideki Mochizuki;Manabu Tashiro;Michiko Kano;Yumiko Sakurada

239
Citations
The physiological and pathophysiological roles of neuronal histamine: an insight from human positron emission tomography studies.

Kazuhiko Yanai;Manabu Tashiro

238
Citations
Propagation of pathological α-synuclein in marmoset brain.

Aki Shimozawa;Aki Shimozawa;Maiko Ono;Maiko Ono;Daisuke Takahara;Airi Tarutani;Airi Tarutani

224
Citations
Roles of histamine in regulation of arousal and cognition : functional neuroimaging of histamine H1 receptors in human brain

Manabu Tashiro;Hideki Mochizuki;Kentaro Iwabuchi;Yumiko Sakurada

222
Citations
In vivo evaluation of a novel tau imaging tracer for Alzheimer’s disease

Victor L. Villemagne;Shozo Furumoto;Michelle T. Fodero-Tavoletti;Rachel S. Mulligan

201
Citations
Tau PET imaging in Alzheimer's disease.

Nobuyuki Okamura;Ryuichi Harada;Shozo Furumoto;Hiroyuki Arai

200
Citations
Cerebral circulation and oxygen metabolism associated with subclinical periventricular hyperintensity as shown by magnetic resonance imaging

Kenichi Meguro;Jun Hatazawa;Tatsuo Yamaguchi;Masatoshi Itoh

198
Citations
Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls

Seiji Nishino;Eiko Sakurai;Sona Nevsimalova;Yasushi Yoshida

196
Citations
Role of histamine H1 receptor in pain perception: a study of the receptor gene knockout mice

Jalal Izadi Mobarakeh;Shinobu Sakurada;Sou Katsuyama;Motoharu Kutsuwa

193
Citations